Auburn, WA 6/20/13; Tacoma, Washington 6/18/13—Syntrix Biosystems has announced a final judgment of $115 million in its 2010 patent infringement case against Illumina in the US District Court for the Western District of Washington (see IBO 4/30/11). In March, a jury found Illumina guilty of infringing US Patent No. 6,951,682 covering synthetic matrix and array […]
Matthews, NC 5/9/13; Matthews, NC 5/13/13; Uppsala, Sweden 5/13/13—CEM announced that its European Patent No. 1,491,552 covering microwave-assisted solid phase peptide synthesis was upheld in an oral proceeding at the European Patent Office (EPO), following a word change for clarification. CEM stated that the opposition proceeding was initiated by Biotage in an attempt to revoke […]
Los Angeles, CA 5/10/13; Los Angeles, CA 5/31/13—OpenGate Capital, which last year acquired Thermo Fisher Scientific’s Laboratory Workstation business (see IBO 10/31/12), has filed suit against Thermo in the US District Court for the Central District of California. OpenGate alleges that Thermo “engaged in a scheme to induce the sale of the Hamilton Entities to […]
IBO’s first patent litigation article for 2013 summarizes new patent infringement litigation involving instrument and lab product companies, as well as settlements and development in ongoing suits. New Suits In the US District Court of Delaware, Illumina is the defendant in a case brought by optics firm Cirrex Systems (see table, page 3). Cirrex alleges […]
San Diego, CA 3/14/13; Tacoma, WA 3/14/12—A jury in the US District Court for the Western District of Washington at Tacoma has found that Illumina’s BeadChip array product infringes Syntrix Biosystems’ US Patent No. 6,951,682, entitled “Porous coatings bearing ligand arrays and use thereof” (see IBO 4/30/11). The jury ordered Illumina to pay Syntrix $96 […]
New York, NY 2/11/13—Illumina and its Board members are named as defendants in a lawsuit brought by Vista Capital Management, a Swiss private equity fund. Vista Capital Management owns more than 300,000 shares of Illumina’s publicly traded common stock. According to the complaint filed in US District Court for the Southern District of New York, […]
Washington, DC 11/5/12; Washington, DC 12/28/12—Singulex has withdrawn its filing for an IPO (see IBO 10/15/12) on the New York Stock Exchange, citing current marketplace conditions. Singulex provides immunoassay technology for life science research and diagnostics. The company had intended to publicly offer 4,375,000 shares at a price of $15–$17 per share for net proceeds […]
New York, NY 11/2/12; Carlsbad, CA 11/1/12—Enzo Biochem has announced that a jury in the US Southern District Court in New York City has awarded the company and Yale University $48.6 million in direct infringement penalties after finding that Life Technologies’ sale of capillary electrophoresis systems and reagents from 1998 to 2004 infringed US Patent […]
Mountain View, CA 10/18/12; San Diego, CA 10/18/12—Sequencing services firm Complete Genomics has announced that the US District Court for the Northern District of California issued an order granting its motion for partial summary judgment of invalidity in a patent infringement suit brought by Illumina against the company (see IBO 9/3010). Judge Elizabeth D. Laporte […]
Washington, DC 10/31/12—To resolve charges that Corning’s proposed acquisition of Becton Dickinson’s Discovery Labware Division would be anticompetitive (see IBO 4/15/12), the Federal Trade Commission (FTC) has proposed that Corning enable Sigma-Aldrich to produce cell culture labware. Corning would provide Sigma-Aldrich with assets and assistance for manufacturing Corning’s line of tissue culture–treated (TCT) dishes, multiwell […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
